JPRN-UMIN000030916
Completed
N/A
The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: cross sectional study by KSGCT - The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: KSGCT1701(Bone-Dx)
Kanto Study Group for Cell Therapy0 sites350 target enrollmentApril 1, 2018
ConditionsHematological malignancies
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hematological malignancies
- Sponsor
- Kanto Study Group for Cell Therapy
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who are otherwise classified as unfit by the attending physicians for this research. 2\) Patients who underwent allogeneic and/or autologous transplantation more than once 3\) Patients with multiple myeloma
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
ong-term observation on adult bone mineral density and lifestyle-related diseases prevention with daily lemon intake in Osakikamijima Town, Hiroshima prefectureJPRN-UMIN000025818SAPPORO HOLDINGS Ltd.170
Recruiting
N/A
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritisDRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60
Completed
N/A
Evaluation of bone mineral density and bone metabolism during treatment with januskinaseinhibitors baricitinib or tofacintib in patients with rheumatoid arthritisM05.80M06.00DRKS00020780Campus Kerckhoff der Justus Liebig Universität Giessen, Abteiliung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin89
Recruiting
N/A
Study of bone mineral density and renal function in cured patients of hyperparathyroidism.CTRI/2019/05/019365Department of Endocrinology
Active, Not Recruiting
Phase 1
ong-term bone mineral density follow-up in subjects completing PRIMROSE 1 or PRIMROSE 2Treatment of heavy menstrual bleeding associated with uterine fibroids.MedDRA version: 21.1Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2021-000452-19-BGObsEva S.A.400